BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18631796)

  • 1. Neuropathology and HIV dementia.
    Pelle MT; Bazille C; Gray F
    Handb Clin Neurol; 2008; 89():807-18. PubMed ID: 18631796
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuropathology and neurodegeneration in HIV infection.
    Jellinger KA
    Clin Neuropathol; 2001; 20(6):276-7. PubMed ID: 11758784
    [No Abstract]   [Full Text] [Related]  

  • 3. Human immunodeficiency virus-associated dementia: clinical aspects, biology, and treatment.
    Venkataramana A; Sacktor N
    Handb Clin Neurol; 2008; 89():799-806. PubMed ID: 18631795
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell death mechanisms in HIV-associated dementia: the involvement of syncytia.
    Nardacci R; Antinori A; Kroemer G; Piacentini M
    Cell Death Differ; 2005 Aug; 12 Suppl 1():855-8. PubMed ID: 15846379
    [No Abstract]   [Full Text] [Related]  

  • 5. [HIV associated encephalopathy after highly active antiretroviral therapy (HAART)].
    Kishida S
    No To Shinkei; 2004 Apr; 56(4):301-10. PubMed ID: 15237721
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe HIV-1 encephalitis and development of cerebral non-Hodgkin lymphoma in a patient with persistent strong HIV-1 replication in the brain despite potent HAART -- case report and review of the literature.
    Baeuerle M; Schmitt-Haendle M; Taubald A; Mueller S; Walter H; Pfeiffer C; Manger B; Harrer T
    Eur J Med Res; 2005 Jul; 10(7):309-16. PubMed ID: 16055403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brueghel syndrome as a new manifestation of HIV encephalopathy.
    Wicki J; Germanier Y; Sztajzel R; Burkhard PR
    Eur Neurol; 2008; 60(2):107-8. PubMed ID: 18552500
    [No Abstract]   [Full Text] [Related]  

  • 8. [HIV infection, acquired immunodeficiency syndrome (AIDS)].
    Izumo S
    Nihon Rinsho; 2004 Jan; 62 Suppl():219-23. PubMed ID: 15011353
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments.
    Gray F; Adle-Biassette H; Chretien F; Lorin de la Grandmaison G; Force G; Keohane C
    Clin Neuropathol; 2001; 20(4):146-55. PubMed ID: 11495003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of current antiretroviral therapies on neuroAIDS.
    Vivithanaporn P; Gill MJ; Power C
    Expert Rev Anti Infect Ther; 2011 Apr; 9(4):371-4. PubMed ID: 21504390
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic conundrum: AIDS therapies may be double-edged swords.
    Clifford DB
    Neurology; 2010 Apr; 74(16):1248-9. PubMed ID: 20338919
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug treatment for HIV-1-associated dementia.
    von Giesen HJ; Arendt G
    Curr Opin Investig Drugs; 2002 Nov; 3(11):1643-6. PubMed ID: 12476967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit or toxicity from neurologically targeted antiretroviral therapy?
    Brew BJ
    Clin Infect Dis; 2010 Mar; 50(6):930-2. PubMed ID: 20146628
    [No Abstract]   [Full Text] [Related]  

  • 14. Crystal meth use worsens HIV-related brain damage.
    Gadd C
    IAPAC Mon; 2005 Apr; 11(4):109. PubMed ID: 16110548
    [No Abstract]   [Full Text] [Related]  

  • 15. Highly active antiretroviral therapy and human immunodeficiency virus encephalitis.
    Cook JE; Dasgupta S; Middaugh LD; Terry EC; Gorry PR; Wesselingh SL; Tyor WR
    Ann Neurol; 2005 Jun; 57(6):795-803. PubMed ID: 15852478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Could differential virological characteristics account for ongoing viral replication and insidious damage of the brain during HIV 1 infection of the central nervous system?
    Vissers M; Stelma FF; Koopmans PP
    J Clin Virol; 2010 Dec; 49(4):231-8. PubMed ID: 20833583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral therapy and its influence on the stage of brain damage in patients with HIV - 1H MRS evaluation.
    Tarasów E; Wiercińska-Drapało A; Jaroszewicz J; Orzechowska-Bobkiewicz A; Dzienis W; Prokopowicz D; Walecki J
    Med Sci Monit; 2004 Jun; 10 Suppl 3():101-6. PubMed ID: 16538209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus encephalopathy: cognitive and radiologic improvement after antiretroviral therapy.
    Silva MT; Wagner S; Grinsztejn B
    Arch Neurol; 2009 Aug; 66(8):1040-1. PubMed ID: 19667231
    [No Abstract]   [Full Text] [Related]  

  • 19. Parkinsonism in hiv-infected patients on highly active antiretroviral therapy.
    Tisch S; Brew B
    Neurology; 2009 Aug; 73(5):401-3. PubMed ID: 19652146
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of HIV infection from the neurologic viewpoint. Therapy must reach the brain].
    von Giesen HJ; Köller H; Arendt G
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():46-50. PubMed ID: 12043074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.